Oncopharmpod
Lifileucel & FLAUR2 Updates
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:17:27
- Mas informaciones
Informações:
Sinopsis
An exciting new cellular therapy, lifileucel, is approved for metastatic melanoma. The FLAURA2 trial of osimertinib + chemotherapy has led to an FDA approval, but questions remain about a possible new standard of care. And a few minor updates on tepotinib.
